Clinlogix,
a next-generation clinical research organization, is widely acknowledged as pioneering the use of innovative business
practices and technologies to provide comprehensive clinical development services for pharmaceutical, biotech and medical
device companies engaged in clinical trials and programs. A global service provider founded in 1999, Clinlogix supports the
clinical development of drugs, biologics, devices and diagnostics in Discovery and Phase I through IV clinical trials,
complying with worldwide regulatory requirements. Clients may choose full-service clinical development or functional
services as-needed, in more than a dozen therapeutic specialties. Clinlogix prides itself on fully integrating with
clients and partners, to the extent that we work as an extension of the team. This hands-on approach facilitates
communication and decision-making for more effective execution of the clinical development program. Using a Web-based
Virtual Integration Partner™ platform enables Clinlogix to assemble the people, processes and technologies
necessary to achieve each client’s objectives. Certified by the Women’s Business Enterprise National
Council and a member of the Association of Clinical Research Organizations, Clinlogix has succeeded in delivering
quality and compliant results, on time and on budget to over 90 studies.
Download our brochure to learn more about how we Innovate and Integrate to Execute you clinical studies. |
